Putnam Investments’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$10.1M Buy
272,146
+4,955
+2% +$187K 0.01% 325
2023
Q3
$10.2M Buy
267,191
+27,184
+11% +$1.11M 0.02% 309
2023
Q2
$8.66M Sell
240,007
-45,656
-16% -$1.56M 0.01% 344
2023
Q1
$10.9M Sell
285,663
-24,137
-8% -$1.13M 0.02% 294
2022
Q4
$17.6M Sell
309,800
-629
-0.2% -$32.2K 0.03% 205
2022
Q3
$12.3M Sell
310,429
-2,867
-0.9% -$127K 0.02% 256
2022
Q2
$13.8M Buy
313,296
+2,207
+0.7% +$95.5K 0.02% 245
2022
Q1
$12.4M Sell
311,089
-8,880
-3% -$316K 0.02% 302
2021
Q4
$12.9M Buy
319,969
+10,414
+3% +$389K 0.02% 318
2021
Q3
$12.6M Buy
309,555
+23,916
+8% +$1,000K 0.02% 316
2021
Q2
$13M Hold
285,639
0.02% 320
2021
Q1
$11.9M Buy
285,639
+128,016
+81% +$5.84M 0.02% 344
2020
Q4
$6.73M Buy
+157,623
New +$5.67M 0.01% 444
2017
Q2
Sell
-66,359
Closed -$860K 1183
2017
Q1
$860K Sell
66,359
-8,150
-11% -$103K ﹤0.01% 1037
2016
Q4
$736K Sell
74,509
-2,093
-3% -$22.9K ﹤0.01% 1064
2016
Q3
$925K Sell
76,602
-50,726
-40% -$518K ﹤0.01% 1033
2016
Q2
$1.1M Buy
127,328
+42,788
+51% +$422K ﹤0.01% 1084
2016
Q1
$801K Buy
84,540
+1,756
+2% +$16.5K ﹤0.01% 1158
2015
Q4
$1.44M Buy
82,784
+29,932
+57% +$477K ﹤0.01% 1057
2015
Q3
$710K Buy
+52,852
New +$1.06M ﹤0.01% 1246

Other funds holding HALO

Putnam Investments's HALO Position: Q4 2023 in Review

Putnam Investments increased its Halozyme (HALO) stake by 1.9% in Q4 2023, buying an estimated $187K and bringing the position to 272,146 shares worth $10.1M. The position accounts for 0.01% of the portfolio, ranked #325.

Putnam Investments first reported a position in HALO in Q3 2015 and has held it in 20 quarters since. The position peaked at $17.6M in Q4 2022. 410 funds tracked by Wall St. Rank hold HALO as of Q4 2023.

  • Putnam Investments held 272,146 shares of Halozyme worth $10.1M as of Q4 2023.
  • Putnam Investments bought 4,955 Halozyme shares in Q4 2023, an estimated $187K.
  • Halozyme made up 0.01% of Putnam Investments's portfolio in Q4 2023, its #325 holding.
  • Putnam Investments first reported a position in Halozyme in Q3 2015 and has held it in 20 quarters since.
  • Putnam Investments's Halozyme position peaked at $17.6M in Q4 2022.
  • 410 funds tracked by Wall St. Rank held Halozyme as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.